Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'U.S. Point of Care Glucose Testing Market, -' returned 26 results - Page 1 of 2   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Point of Care Diagnostic Testing World Markets   TriMark Publications, July 2011, Pages: 375 .2: Global Population of Persons with Diabetes, 1995 and 2025 89 Table 4.3: Professional Glucose Testing Market for POCT Worldwide Revenue and Forecasts, 2001-2012 90 Table 4.4: U.S. Point of Care Glucose Point of Care Diagnostic Testing Sector Trends   TriMark Publications, Nov 2011, Pages: 189 days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs 2007 U.S. Hospital Point-of-Care Survey   Enterprise Analysis Corporation (EAC), Oct 2007 - Hemocue - HemoSense - Instrument Laboratory - ITC - LifeScan - Medtronic - Metrika - Nova Biomedical - Orasure - Osmetech - Radiometer - Roche - Siemens - Waters Medical 2007 U.S. Hospital Point-of-Care U.S. Point-of-care Testing Markets   Frost & Sullivan, March 2010, Pages: 198 but outside a central laboratory. Products marketed as over the counter where consumers can purchase at retail outlets are excluded. This Frost & Sullivan research service titled U.S. Point-of-care Testing Blood Glucose Testing and Diabetes Management   TriMark Publications, April 2009, Pages: 366 , Growth, Share and Competitors 54 3.1.2.1 Worldwide Market 54 3.1.2.2 U.S. Market 56 3.1.2.3 European Market 59 3.1.2.4 Asian Market 60 3.2 Glucose Analytical Test Methods 74 3.2.1 Glucose Oxidase 74 3 Strategic Analysis of the Global In Vitro Diagnostics Market   Frost & Sullivan, July 2010, Pages: 122 -of-care testing, molecular diagnostics, hemostasis, tissue diagnostics, self-monitoring blood glucose (SMBG) testing, and hematology. Market Overview Widening Patient Base and Surge in Healthcare U.S. Glucose Monitoring Markets and Emerging Technologies   Frost & Sullivan, Dec 2005 markets. Under-penetrated Market Segments Provide New Growth Opportunities Despite the increasing maturity of the traditional U.S. glucose strips market, the emergence of niche application markets U.S. Diabetes Diagnostic Testing Markets   Frost & Sullivan, July 2001 Trends I. Pricing Trends J. Competitive Structure K. Market Share Analysis L. Product Analysis M. Strategic Recommendations N. ME Awards O. Supplement 3. U.S. Laboratory-Based Glucose Test U.S. Market for In-Vitro Diagnostics 2011 (Immunochemistry, Molecular Diagnostics, Blood Donor Screening, Hemostasis, Hematology and Point-Of-Care Testing) (Executive Summary)   iData Research, Sep 2011, Pages: 9 .9 Competitive Analysis U.S. Market for In-Vitro Diagnostics 2011 (Immunochemistry, Molecular Diagnostics, Blood Donor Screening, Hemostasis, Hematology and Point-Of-Care Testing) (Executive Summary) Diabetics: Attitudes and Behaviors in the United States 2008   Mintel, Aug 2008, Pages: 81 outlets, 2006/07 and 2007/08 Segment Performance—Glucose Testing Devices Key points Glucose monitors drop through FDMx but are estimated to grow overall Figure 8: U.S. sales and forecast of glucose testing Cardiac Marker Diagnostic Testing Markets   TriMark Publications, Nov 2011, Pages: 139 Companies 14 Table 2.3: Global Clinical Laboratory Market Sales, 1998-2011 15 Table 2.4: U.S. In Vitro Central Lab Diagnostic Testing, 2003-2012 15 Table 2.5: Global Point of Care Revenues, 2005-2012 15 Table High-Growth Diagnostic Testing Markets   TriMark Publications, Nov 2008, Pages: 310 .9: The Cardiac Marker Market for Testing in the U.S., 2001-2010 72 Table 5.10: Market Share of Cardiac Marker Segment 72 Table 5.11: U.S. Market for Point of Care Cardiac Marker Testing, 2000-2010 75 Table 5 Molecular Diagnostics in Cancer Testing   TriMark Publications, July 2011, Pages: 214 and Comparison of Methods 4.2.3 Competitive Structure and Market Share Analysis 4.2.3.1 Breast Cancer Molecular Diagnostic Testing Market Size 4.2.3.1.1 Global Market 4.2.3.1.2 U.S. Market 4.2.3.1.3 European U.S. Market for In-Vitro Diagnostics 2011 (Immunochemistry, Molecular Diagnostics, Blood Donor Screening, Hemostasis, Hematology and Point-Of-Care Testing)   iData Research, Sep 2011, Pages: 322 : MARKET BREAKDOWN BY TESTING SETTING U.S. Market for In-Vitro Diagnostics 2011 (Immunochemistry, Molecular Diagnostics, Blood Donor Screening, Hemostasis, Hematology and Point-Of-Care Testing) Clinical Laboratory Testing Volume 2: Business Strategies   TriMark Publications, Sep 2010, Pages: 117 . The Clinical Laboratory Testing Market 3.1 U.S. Market 3.1.1 Hospital-based Clinical Laboratories 3.1.2 Commercial Clinical Laboratory Testing 3.1.3 Physician Office Laboratories (POLs) 3.2 Clinical Lab Clinical Laboratory Testing Volume 1: Reagents and Instruments   TriMark Publications, Sep 2010, Pages: 308 Tests in Top European Markets Table 4.26: PAP Tests in Top Asian Markets Table 4.27: Drugs of Abuse Testing Market for POCT Worldwide, 2006-2015 Table 4.28: U.S. Point of Care Drugs of Abuse Testing Global Top 10 Medical Devices Market (2010 – 2015)   Markets and Markets, July 2011, Pages: 575 .2.1 Self Testing Giving The Momentum 10.2.2 Many Advantages Of Point-Of-Care Testing 10.2.3 Highly Fragmented Industry 10.3 Blood Glucose Monitoring 10.4 Blood Chemistry & Electrolyte 10.5 Pregnancy Strategic Assessment of the U.S. Point-of-Care Testing Markets   Frost & Sullivan, Jan 1998 The total U.S. point-of-care testing market generated revenues of $1.6 billion in 1996. This report from Frost & Sullivan assesses the current condition of this market, and explains why Future Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies   Venture Planning Group, Nov 2011, Pages: 600 Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares U.S.A. A. Executive Summary B. Business Environment 1. Health Care Expenditures 2 U.S. Home Diagnostics and Monitoring Device Markets   Frost & Sullivan, Nov 1998 - Market Engineering Unit Shipment and Revenue Forecasts (1994-2004) - Point-of-Care Rapid Tests for Drugs of Abuse - Market Drivers - Market Restraints - Competitive Analysis - Evolving Technologies Results:  First -   Prev -   1 -   2 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network